Canadian Online Pharmacy

CDER New June 4, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 03, 2014


New and Generic Drug Approvals

June 2, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Divalproex Sodium divalproex sodium Tablet, Extended Release;Oral Aurobindo Pharma Ltd Approval
Dymista azelastine hydrochloride; fluticasone propionate Spray, Metered;Nasal Meda Pharms Manufacturing Change or Addition
Kyprolis carfilzomib Powder;Intravenous Onyx Pharms Manufacturing Change or Addition
Mefenamic Acid mefenamic acid Capsule;Oral Vintage Pharms Llc Approval
Methadose methadone hydrochloride Concentrate;Oral Mallinckrodt Manufacturing Change or Addition
Ms Contin morphine sulfate Tablet, Extended Release;Oral Purdue Pharma Lp Manufacturing Change or Addition
Oxycodone Hydrochloride oxycodone hydrochloride Capsule;Oral Lehigh Valley Manufacturing Change or Addition
Oxycodone Hydrochloride oxycodone hydrochloride Solution;Oral Vistapharm Manufacturing Change or Addition
Reyataz atazanavir sulfate Capsule;Oral Bristol Myers Squibb Efficacy Supplement with Clinical Data to Support
Reyataz atazanavir Powder;Oral Bristol Myers Squibb Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery